IRIS
ARVIGO, MARICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.041
Totale 5.041
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.041
Totale 5.041
Salva come PNG Salva come JPEG
Città #
Genova 4.072
Rapallo 526
Genoa 404
Vado Ligure 35
Bordighera 4
Totale 5.041
Salva come PNG Salva come JPEG
Nome #
Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins 245
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 174
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 157
Pancreatic Islet Cell Tumor Secreting Insulin-Like Growth Factor Type-II in a Dog. 139
Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings. 138
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 136
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 133
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells 129
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 127
Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture 122
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog. 121
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 121
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with turner's syndrome in culture 120
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 115
Somatostatin receptor scintigraphy in thoracic diseases 113
Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture. 112
Canine pancreatic islet cell tumours secreting insulin-like growth factor type 2: A rare entity 111
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 111
Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J.Clin.Endocrinol.Metab. 80 (4):1318-1324, 1995. 108
In memory of Francesco Maria Minuto. 107
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 104
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation 102
Role of adiponectin and leptin on body development in infants during the first year of life 102
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 100
Somatostatin receptor pathophysiology in the neuroendocrine system 100
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 99
Role of somatostatin analogues in the management of immunolymphoproliferative diseases 97
Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily 94
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database 94
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 93
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells 93
Novel chimeric somatostatin analogs: facts and perspectives 92
Dopamine receptor expression and function in corticotroph pituitary tumors. 92
IGF-I production by adult rat hepatocytes is stimulated by transforming growth factor alfa and trasforming growth factor beta1 90
Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture 90
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex 90
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study. 86
Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. 85
Somatostatin, somatostatin analogs and somatostatin receptor dynamics in the biology of cancer progression. 80
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 78
The IGF system and bone 77
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 76
Serum IGF-I concentration is positively associated with 25-hydroxyvitamin D level and increases upon treatment with vitamin D. 72
Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1beta in vitro 69
Abstracts of the 6th Annual ENETS Conference, Granada, Spain, March 5–7, 2009 59
Rationale for treating cancer with somatostatin analogs. 57
Octreotide and pasireotide combination treatment in somatotroph tumor cells: Predominant role of sst2 in mediating ligand effects 56
The role of somatostatin analogs in the management of immunoproliferative disease 38
β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids 37
Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies. 25
Corrigendum to "Regulation of prostate cancer cell proliferation by somatostatin receptor activation" [Mol. Cell. Endocrinol. 315 (1-2) (2010) 254-262] 17
Potential indications for somatostatin analogues: immune system and limphoproliferative disorders 16
Totale 5.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.173
article - articoli 14.002
book - libri 0
conference - conferenze 171
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.299 0 38 76 93 126 144 190 91 123 232 140 46
2020/2021474 28 31 45 126 30 24 7 44 26 56 30 27
2021/2022667 14 44 65 91 18 40 32 148 34 58 28 95
2022/2023622 58 62 7 70 79 101 0 50 96 5 90 4
2023/2024307 18 38 4 49 18 48 23 12 13 5 38 41
2024/202549 36 13 0 0 0 0 0 0 0 0 0 0
Totale 5.099